| NDC Code | 60977-319-03 |
|---|
| Package Description | 4 BOX in 1 CARTON (60977-319-03) > 1 VIAL, SINGLE-DOSE in 1 BOX (60977-319-02) > 1 mL in 1 VIAL, SINGLE-DOSE (60977-319-44) |
|---|
| Product NDC | 60977-319 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Hylenex Recombinant |
|---|
| Non-Proprietary Name | Hyaluronidase Recombinant Human |
|---|
| Dosage Form | INJECTION, SOLUTION |
|---|
| Usage | SUBCUTANEOUS |
|---|
| Start Marketing Date | 20051202 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA021859 |
|---|
| Manufacturer | Baxter Healthcare Corporation |
|---|
| Substance Name | HYALURONIDASE RECOMBINANT HUMAN |
|---|
| Strength | 150 |
|---|
| Strength Unit | [USP'U]/mL |
|---|
| Pharmacy Classes | Endoglycosidase [EPC],Glycoside Hydrolases [Chemical/Ingredient] |
|---|